ACTIVE

Oelegem Pharma

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result237 k €-13,1 %over 1 year
Gross margin541,1 k €+10,9 %over 1 year
Equity351,8 k €+3,2 %over 1 year
Workforce2,3 ETP+9,5 %over 1 year

Identity

Source · BCE/KBO

Oelegem Pharma is a Private company with limited liability incorporated in 2013. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Ranst. It employs on average 2,3 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0538.973.372
Incorporation
25/09/2013
Legal form
Private company with limited liability
Registered office
Schildesteenweg 41 box 1
2520 Ranst · FlandreSee on map
Contributed capital
100 000,00 €
Latest accounts
31/12/2025
Average workforce
2,3 ETP
Joint committees (1)
  • 313
Signals
ProfitablePositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 12 filings

Trend over 11 financial years

20252024202320222021
Income statement
Gross margin541,1 k €487,7 k €384,3 k €207,3 k €266,7 k €
EBITDA350,1 k €346,2 k €217,2 k €65,7 k €154,1 k €
Operating result277,3 k €313,8 k €158,2 k €-55,9 k €71,2 k €
Net result237 k €272,9 k €138,2 k €-86,8 k €28,1 k €
Balance sheet
Equity351,8 k €340,8 k €289,9 k €186,7 k €273,5 k €
Total assets1,8 M €1,6 M €1,1 M €627,8 k €818 k €
Cash224,8 k €102,6 k €146,1 k €15,5 k €21,7 k €
Debts1,5 M €1,2 M €764,7 k €441,1 k €544,1 k €
Other
Workforce2,3 ETP2,1 ETP1,0 ETP2,1 ETP1,9 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 4 ended

Active mandates

BeSt Pharma Management

Director · since 02 janvier 2023 · 0794.803.647

Represented by De Ceuster Stéphanie

Active

Ended mandates

BeSt Pharma Management

Director · since 02 janvier 2023 · 0794.803.647

Represented by De CEUSTER STÉPHANIE

Ended
ANNE-MARIE BUNGENEERS

Manager · since 25 septembre 2013

Ended
Anne-Marie BUNGENEERS

Director · since 25 septembre 2012

Ended
Anne-Marie BUNGENEERS

Manager · since 25 septembre 2012

Ended

Full financial information

Source · NBB
202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date24/08/202620/08/202505/08/202425/07/202327/07/202227/07/2021
General meeting18/06/202619/06/202520/06/202415/06/202316/06/202217/06/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for 7 days

Annual accounts filings

Source · NBB, 12 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202518/06/202624/08/2026DutchPDF
Abridged model31/12/202419/06/202520/08/2025DutchPDF
Abridged model31/12/202320/06/202405/08/2024DutchPDF
Abridged model31/12/202215/06/202325/07/2023DutchPDF
Abridged model31/12/202116/06/202227/07/2022DutchPDF
Abridged model31/12/202017/06/202127/07/2021DutchPDF
Abridged model31/12/201918/06/202022/07/2020DutchPDF
Abridged model31/12/201820/06/201927/06/2019DutchPDF
Abridged model31/12/201721/06/201802/07/2018DutchPDF
Abridged model31/12/201615/06/201720/06/2017DutchPDF
Abridged model31/12/201516/06/201605/07/2016DutchPDF
Abridged model31/12/201418/06/201520/07/2015DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 4 ended

Active mandates

BeSt Pharma Management

Director · since 02 janvier 2023 · 0794.803.647

Represented by De Ceuster Stéphanie

Active

Ended mandates

BeSt Pharma Management

Director · since 02 janvier 2023 · 0794.803.647

Represented by De CEUSTER STÉPHANIE

Ended
ANNE-MARIE BUNGENEERS

Manager · since 25 septembre 2013

Ended
Anne-Marie BUNGENEERS

Director · since 25 septembre 2012

Ended
Anne-Marie BUNGENEERS

Manager · since 25 septembre 2012

Ended

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Registered office09/05/2025
    MAATSCHAPPELIJKE ZETEL
    PDF
  • Other24/03/2023
    BENAMING - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …)
    PDF
  • Mandates02/02/2023
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Other07/10/2013
    RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025237 k €↓
  2. 2024
    Annual accounts 2024272,9 k €↑
  3. 2023
    Annual accounts 2023138,2 k €↑
  4. 2022
    Annual accounts 2022-86,8 k €↓
  5. 2022
    Name changeOelegem Pharma
  6. 2021
    Annual accounts 202128,1 k €↓
  7. 2021
    Name changeBUPHAR
  8. 2020
    Annual accounts 202035,8 k €↑
  9. 2019
    Annual accounts 201935,2 k €↑
  10. 2018
    Annual accounts 201831,3 k €↓
  11. 2017
    Annual accounts 201731,3 k €↓
  12. 2015
    Annual accounts 201535,1 k €↑
  13. 2014
    Annual accounts 2014-31,6 k €
  14. 25/09/2013
    IncorporationPrivate company with limited liability